Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults젊은 성인의 모든 SARS-CoV-2 감염에 대한 Covid-19 백신 및 이전 감염의 효과 및 보호 기간Article Published on 2022-07-082022-09-11 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Ad26 Ad26.COV2.S Adults B.1.617 BNT162b2 caused Community contribute COVID-19 vaccination COVID-19 vaccines decrease delta variant dominant dropped Effectiveness Estimated evaluate General population increase in infected individuals Infection mRNA mRNA vaccine mRNA-1273 offer provide repeated SARS-COV-2 infection SARS-CoV-2 variant Spread surveillance testing vaccinated individual vaccinated individuals vaccination Vaccine variant while [DOI] 10.1038/s41467-022-31469-z PMC 바로가기 [Article Type] Article
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum백신 및 BA.1 혈청에서 SARS-CoV-2 Omicron BA.4 및 BA.5의 항체 탈출Article Published on 2022-07-072022-09-11 Journal: Cell [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] antibody antibody escape AstraZeneca BA.4 BA.5 breakthrough infections COVID-19 described dominant dose driving immune Immune Serum individual infections initial Lineage monoclonal antibodies Mutation neutralization omicron Pfizer raising recent Receptor-binding domain reduced reductions in replaced REPLACED BY SARS-CoV-2 Sequencing serum significant reductions South Africa spikes Spread the receptor-binding domain Vaccine vaccine breakthrough infections variant VoC [DOI] 10.1016/j.cell.2022.06.005 PMC 바로가기 [Article Type] Article
Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study캐나다 온타리오주 장기요양원에서 오미크론 변이에 대한 covid-19 mRNA 백신 4차 접종의 효과: 음성 설계 연구 테스트Article Published on 2022-07-062022-09-11 Journal: The BMJ [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval BNT162b2 Canada Care Chain Reaction Characteristics Comorbidities Control death dominant dose doses Effectiveness Hospital admission Infection Logistic regression long term mRNA mRNA COVID-19 vaccines mRNA vaccine mRNA-1273 multivariable logistic regression Older Omicron variant outcome outcomes polymerase chain polymerase chain reaction positive recipient reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test Seven symptomatic symptomatic infection Test test negative test result tested the vaccine vaccination Vaccine vaccine dose was used [DOI] 10.1136/bmj-2022-071502 PMC 바로가기 [Article Type] Article
From 15 Minutes to 15 Seconds: How the Delta Variant Changed the Risk of Exposure to COVID-19. A Comparative Epidemiological Investigation Using Community Mobility Data From the Metropolitan Area of Genoa, Italy15분에서 15초로: Delta 변형이 COVID-19에 대한 노출 위험을 어떻게 변화시켰는지. 이탈리아 제노바 수도권 지역사회 이동성 자료를 이용한 비교 역학조사Article Published on 2022-07-052022-09-11 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] absolute risk Area close contact Comparative competitive advantage COVID-19 COVID-19 pandemic crowding defined Delta delta variant deviation dominant effective epidemiological Epidemiological investigation Evolution exposure exposure to game game theory Google Map Google maps investigation Italy lowest median minute minutes Mobility offer pandemic product public health reduce Relative risk response risk second wave significantly social distancing Unilateral vaccination variant visit duration was obtained [DOI] 10.3389/fpubh.2022.872698 PMC 바로가기 [Article Type] Article
Whole-genome analysis and mutation pattern of SARS-CoV-2 during first and second wave outbreak in Gwangju, Republic of Korea대한민국 광주에서 1차 및 2차 유행 중 SARS-CoV-2의 전체 게놈 분석 및 돌연변이 패턴Article Published on 2022-07-052022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, [키워드] Analysis analyzed Cell culture circulating clade clinical clinical samples collected conducted Culture Deletion deletions determine dominant feature genetic diversity genomic genomic alteration high viral load in-depth analysis indicate Missense mutated Mutation Next-generation sequencing nucleic acid Nucleic acid purification outbreak Pathogenesis pathogenesis of SARS-CoV-2 Patient phylogenetic analyses Phylogenetic analysis Point mutation Proteins Region regions Research SARS-CoV-2 SARS-CoV-2 genome sequence SARS-CoV-2 genome sequences SARS-CoV-2 isolates SARS-CoV-2 pathogenesis second wave significant difference South Korea statistical analysis therapeutic Viral load was performed whole genome [DOI] 10.1038/s41598-022-14989-y PMC 바로가기 [Article Type] Article
Analysis of COVID-19-Related Croup and SARS-CoV-2 Variant Predominance in the US미국에서 COVID-19 관련 크룹 및 SARS-CoV-2 변종 우세 분석Article Published on 2022-07-012022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] association cross-sectional cross-sectional study Croup dominant SARS-CoV-2 SARS-CoV-2 variant [DOI] 10.1001/jamanetworkopen.2022.20060 PMC 바로가기 [Article Type] Article
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse originsBA.1 및 가능한 마우스 기원과 비교하여 Omicron BA.2 변이체의 증가된 감염성 및 면역 회피를 위한 구조적 및 생화학적 메커니즘Article Published on 2022-07-012022-09-11 Journal: Cell Research [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] ACE2 ACE2 binding addition antibody bind binding biochemical combating dominant effective Evolution exhibit high affinity high potency human ACE2 immune evasion implication infections infective inhibit interactions mechanism neutralization activity omicron open pathway RBDs Receptor-binding domain receptor-binding domains reveal SARS-CoV-2 viral shown spike trimer Strains Structure structures therapeutic trimer variant Viral viral infections wildtype WT spike [DOI] 10.1038/s41422-022-00672-4 PMC 바로가기 [Article Type] Article
Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York CitySARS-CoV-2 오미크론 변종 확산의 핫스팟: 뉴욕시의 교훈Article Published on 2022-07-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] Analysis biological properties biological property coronavirus coronavirus disease COVID-19 COVID-19 pandemic dispersal dominant effort epicenter epidemiological Epidemiology equity Evolution Future genetic variability genetic variability evolution. genomic genomic data Immune escape Infection prevention Large-scale testing lesson Mutation New York City omicron pandemic public health system public health systems SARS Coronavirus SARS coronavirus classification SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants South Africa Spread Surveillance Transmissibility United Kingdom vaccination Vaccine variant [DOI] 10.1002/jmv.27691 PMC 바로가기 [Article Type] Article
Advances in the Omicron variant developmentOmicron 변종 개발의 발전Review Published on 2022-07-012022-09-11 Journal: Journal of internal medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus addition advance Alpha Amino acid amino acids Antiviral antiviral agent Antiviral agents antiviral drugs approved Beta booster dose booster doses Casirivimab circulating coronavirus COVID-19 Delta disease dominant dose drug effective entry of SARS-CoV-2 Epidemiology epitope Epitopes Gamma greater greater transmissibility growth advantage Health Organization humoral Imdevimab Immune escape incidence Infection inhibit Mild mild illness molecular molnupiravir monoclonal monoclonal antibodies monoclonal antibody mutations offer omicron Omicron variant pandemic Paxlovid pharmacological agent pharmacological agents Remdesivir Research respiratory SARS-CoV-2 SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus Spike protein Spread the spike protein therapeutic to define Transmissibility vaccination Vaccine Vaccines variant variants Viral viral replication VoC WHO World Health Organization [DOI] 10.1111/joim.13478 PMC 바로가기 [Article Type] Review
Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study커큐민, 새로운 SARS-CoV-2 변이체(VOC) Omicron의 스파이크 단백질 억제, in silico 연구Article Published on 2022-07-012022-09-11 Journal: Computers in biology and medicine [Category] COVID19(2023년), SARS, 변종, [키워드] Allicin Amino acid amino acid substitution B.1.1.529 Capsaicin change Chloroquine Cinnamaldehyde complex coronavirus COVID-19 Curcumin demonstrated disrupt docked dominant evaluate Gingerol Immunity in silico in silico study inhibit inhibitory molecular multiple mutation multiple mutations Native new SARS-CoV-2 omicron Omicron variant physiological piperine Protein RBD RBD domain Receptor binding domain S protein Seven specific treatment spike Spike protein Spike-RBD. stability suggested the Spike therapeutic therapeutic agent three-dimensional structure Vaccine variant variant of SARS-CoV-2 VoC was performed [DOI] 10.1016/j.compbiomed.2022.105552 PMC 바로가기 [Article Type] Article